At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm, Sweden, discusses the application of next-generation sequencing for guiding cancer treatment decision-making.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now